Orbactiv cost?

Orbactiv is oritavancin, a single‑dose IV antibiotic for ABSSSI. Prices vary a lot by country, pharmacy, and insurance.

In the United States, the list price for a 1200 mg single-dose vial of Orbactiv is typically in the ballpark of about $3,000 to $4,000. Your actual out‑of‑pocket cost will depend on your insurance coverage, pharmacy, and whether there are any manufacturer or patient‑assistance programs available. Uninsured patients can end up paying several thousand dollars out of pocket.

If you’re outside the U.S., or if you want a tighter estimate (e.g., based on your insurance, or a cash price at a specific pharmacy), tell me your country and whether you have insurance coverage. I can tailor the estimate. I can also compare costs with alternatives like dalbavancin (two-dose regimen) or vancomycin, which have different pricing and administration considerations.